CGTI
Attend.

Attend · CGTI 2027

Your place
in the room.

CGTI is invite-only and closed. Applications are reviewed by Herbert Ryan. A place is offered only when the curation is complete. Hotel Palace Berlin · 10 and 11 February 2027.

DetailsPassPaymentWelcome

Your pass

Nothing is charged here. Payment follows once your place is accepted.

How you join

Member
Enter

For your office

Optional. For an office that registers a leader, and for an invoice that must carry a purchase order.

Registering on behalf of a leader

For the room

Three questions. Shapes who you sit with and what we prepare.

Current challenges

Select up to two

From artisanal to industrialised process
Cost of goods and patient access
Potency assays and comparability
Rapid and real-time release
Vector yield and supply
Tech transfer and scale out
Regional release requirements
Other

Current investment areas

Select up to two

Closed systems and automation
Integrated and real-time analytics
Vector and plasmid supply
Allogeneic and in vivo platforms
CDMO partnerships and capacity
Release and quality systems
Other

Which digital or AI technologies are you actively evaluating or deploying in cell and gene therapy manufacturing?

Select up to two

Closed and automated systems
Robotics and integrated analytics
Process analytical technology and real-time release
Digital twin and process simulation
AI driven process control
Electronic batch records and QMS
None currently active

Where is your organisation's primary focus in quality and release over the next 12 months?

Select one

Potency assays and comparability
Rapid and real-time release
Closed and automated processing
Vector and raw material supply
Tech transfer and CDMO qualification
Regional release and regulatory divergence
Cost of goods reduction

What best describes your organisation's current investment posture in cell and gene therapy manufacturing technology?

Select one

Active procurement · decision within 6 months
Pilot and evaluation stage
Horizon planning · 12-24 months
Strategic review · no immediate mandate
Investment pause · reassessing priorities

What is your typical annual budget influence for technology, equipment and process investments?

Influence means decision authority or material input · not direct control alone

Up to £1M
£1M to £10M
£10M to £100M
£100M to £1B+
Prefer not to disclose

GBX Circle holds your details to review this request and to prepare the room. Privacy

Applications reviewed by Herbert Ryan · herbert@gbxcircle.com · Notifications to hello@gbxcircle.com